BTB01303
BTB01303 is a (glutamate release) inhibitor. Cancer cells release high levels of (glutamate), which disrupts normal bone turnover and may lead to cancer-induced bone pain. BTB01303 has the potential to improve cancer-induced bone pain.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 652129-89-0
- Formule: C15H11Cl2NO3
- Masse moléculaire:324.16
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
Description
In Vitro
Chemical Information
-
CAS No. 652129-89-0
-
Masse moléculaire 324.16
-
Formule C15H11Cl2NO3
-
SMILES
ClC1=CC(/C=N/C2=CC=C3OCOCC3=C2)=C(O)C(Cl)=C1
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)